HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3246-3255

  Chen, Hong P ^a   Denicola, Megan ^a   Qin, Xin ^a   Zhao, Yu ^a   Zhang, Ling ^b   Long, Xi L ^c   Zhuang, Shougang ^b   Liu, Paul Y ^a   Zhao, Ting C ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Cardiogenesis; HDAC; Proteasome system, Stem cell; Survival

Indexed keywords

ACTIN; BUTYRIC ACID; CASPASE 3; CASPASE 6; CASPASE 9; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEASOME; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; HEART CONTRACTION; HEART DEVELOPMENT; HEART MUSCLE CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DNA PRIMERS; EMBRYONIC STEM CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HISTONE DEACETYLASE INHIBITORS; MICE; MYOCARDIUM; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80054981242     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23251     Document Type: Article

References (38)

1. Chan JK, Sun L, Yang XJ, Zhu G, Wu Z,. 2003. Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. J Biol Chem 278 (26): 23515-23521. (Pubitemid 36830170)
2. Cheung P, Allis CD, Sassone-Corsi P,. 2000. Signaling to chromatin through histone modifications. Cell 103: 263-267.
3. Dovey OM, Foster CT, Cowley SM,. 2010. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci USA 107 (18): 8242-8247.
4. Fischle W, Emiliani S, Hendzel MJ, Nagase T, Nomura N, Voelter W, Verdin E,. 1999. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1. Biol Chem 274: 11713-11720.
5. Foster CT, Dovey OM, Lezina L, Luo JL, Gant TW, Barlev N, Bradley A, Cowley SM,. 2010. Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability. Mol Cell Biol 30 (20): 4851-4863.
6. Grozinger CM, Hassig CA, Schreiber SL,. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96: 4868-4873. (Pubitemid 29214503)
7. Hansen JC, Tse C, Wolffe AP,. 1998. Structure and function of the core histone N-termini: More than meets the eye. Biochemistry 37: 17637-17641. (Pubitemid 29023917)
8. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL,. 1998. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci USA 95: 3519-3524. (Pubitemid 28173160)
9. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA,. 2008. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26 (11): 1269-1275.
10. Kee HJ, Sohn IS, Nam KI, Park JE, Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, Kim JK, Kim KK, Epstein JA, Kook H,. 2006. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113: 51-59. (Pubitemid 43958488)
11. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA,. 2006. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113: 2579-2588. (Pubitemid 43948006)
12. Lagger M, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C,. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21 (11): 2672-2681. (Pubitemid 34619383)
13. Lin Q, Schwarz J, Bucana C, Olson EN,. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276 (5317): 1404-1407. (Pubitemid 27235406)
14. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ,. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260. (Pubitemid 27406632)
15. Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J,. 1994. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75 (2): 233-244. (Pubitemid 24228315)
16. McKinsey TA, Zhang CL, Lu J, Olson EN,. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408 (6808): 106-111.
17. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN,. 2010. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143 (1): 35-45.
18. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, Richardson JA, Bassel-Duby R, Olson EN,. 2007. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117 (9): 2459-2467. (Pubitemid 47494347)
19. Rota M, LeCapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas ME, Esposito G, Vitale S, Urbanek K, Casarsa C, Giorgio M, Lüscher TF, Pelicci PG, Anversa P, Leri A, Kajstura J,. 2006. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99 (1): 42-52. (Pubitemid 44297054)
20. Rusty LM, Christopher AD, Matthew JP, Michael H, Jens F, Xiaoxia Q, Joseph AH, James AR, Eric NO,. 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21 (14): 1790-1802.
21. Smith AG,. 2001. Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol 17: 435-462. (Pubitemid 33096183)
22. Song K, Backs J, McAnally J, Qi X, Gerard RD, Richardson JA, Hill JA, Bassel-Duby R, Olson EN,. 2006. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 125 (3): 453-466.
23. Strahl BD, Allis CD,. 2000. The language of covalent histone modifications. Nature 403: 41-45. (Pubitemid 30038513)
24. Su H, Wang X,. 2010. The ubiquitin-proteasome system in cardiac proteinopathy: A quality control perspective. Cardiovasc Res 85 (2): 253-262.
25. Tamaki T, Akatsuka A, Okada Y, Uchiyama Y, Tono K, Wada M, Hoshi A, Iwaguro H, Iwasaki H, Oyamada A, Asahara T,. 2008. Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS One 3 (3): e1789.
26. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM,. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282 (5391): 1145-1147. (Pubitemid 28516247)
27. Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA,. 2007. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 13 (3): 324-331. (Pubitemid 46376684)
28. Tseng A, Stabila J, McGonnigal B, Yano N, Yang MJ, Tseng YT, Davol PA, Lum LG, Padbury JF, Zhao TC,. 2010. Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart. Cardiovasc Res 87 (4): 704-712.
29. Turner BM,. 2000. Histone acetylation and an epigenetic code. Bioessays 22: 836-845.
30. Verdin E, Dequiedt F, Kasler HG,. 2003. Class II histone deacetylases: Versatile regulators. TRENDS in Genetics 19: 286-293. (Pubitemid 36507011)
31. Vigushi DM, Coombes RC,. 2004. Targeted histone deacetylase inhibition for cancer therapy. Curr Cancer Targ 4: 205-218. (Pubitemid 38332557)
32. Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th'ng J, Han J, Yang XJ,. 1999. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19: 7816-7827. (Pubitemid 29493445)
33. Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, Duan Z, Blau CA,. 2009. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 4 (4): 359-369.
34. Yuan X, Wan H, Zhao X, Zhu S, Zhou Q, Ding S,. 2011. Combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 29 (3): 549-553.
35. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN,. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (4): 479-488. (Pubitemid 35232291)
36. Zhang LX, Zhao Y, Cheng G, Guo TL, Chin YE, Liu PY, Zhao TC,. 2010. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am J Physiol Heart Circ Physiol 298 (6): H2154-H2163.
37. Zhao TC, Taher MM, Valerie KC, Kukreja RC,. 2001. p38 Triggers late preconditioning elicited by anisomycin in heart: Involvement of NF-kappaB and iNOS. Circ Res 89 (10): 915-922. (Pubitemid 34627897)
38. Zhao TC, Cheng G, Zhang LX, Tseng YT, Padbury JF,. 2007. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76: 473-481. (Pubitemid 350007465)